|
Butylscopolammonium Bromide
|
D002086 |
[Antimuscarinic quaternary ammonium derivative of scopolamine used to treat cramps in gastrointestinal, urinary, uterine, and biliary tracts, and to facilitate radiologic visualization of the gastrointestinal tract.
] |
|
Butyrates
|
D002087 |
[4-carbon acids, salts, and derivatives of BUTYRIC ACID.
, Derivatives of BUTYRIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxypropane structure.
] |
|
Erlotinib Hydrochloride
|
D03.633.100.786.375 |
|
|
Receptors, GABA-B
|
D12.776.543.750.695.300 |
|
|
Non-alcoholic Fatty Liver Disease
|
D065626 |
[Fatty liver finding without excessive ALCOHOL CONSUMPTION.
] |
|
Familial Primary Pulmonary Hypertension
|
D065627 |
[Familial or idiopathic hypertension in the PULMONARY CIRCULATION which is not secondary to other disease.
] |
|
Butyrylcholinesterase
|
D002091 |
[An aspect of cholinesterase (EC 3.1.1.8).
] |
|
Iridoid Glycosides
|
D02.455.849.575.188.500.500 |
|
|
Intestinal Reabsorption
|
D065628 |
[The re-uptake of substances in the intestines after their prior absorption from the intestines into the PORTAL SYSTEM and reintroduction into the intestines as substances accumulated in the BILE.
] |
|
Butyrylthiocholine
|
D002092 |
[A sulfur-containing analog of butyrylcholine which is hydrolyzed by butyrylcholinesterase to butyrate and thiocholine. It is used as a reagent in the determination of butyrylcholinesterase activity.
] |
|
Brenner Tumor
|
C19.391.630.705.265 |
|
|
Peritoneal Absorption
|
D065629 |
[Uptake of substances from the PERITONEAL CAVITY.
] |
|
Butyrophenones
|
D002090 |
[Compounds containing phenyl-1-butanone.
] |
|
Byssinosis
|
D002095 |
[A condition of BRONCHOCONSTRICTION resulting from hypersensitive reaction to inhaled dust during the initial processing of cotton, flax, or hemp in the textile industry. Symptoms include wheezing and tightness in the chest.
] |
|
C-Peptide
|
D002096 |
[The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin.
] |
|
Groundwater
|
G01.311.355 |
|
|
Locus Coeruleus
|
A08.186.211.132.659.473 |
|
|
Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide
|
D002093 |
[Proposed cholinesterase inhibitor.
] |
|
Republic of Belarus
|
D002094 |
[A country in Eastern Europe, east of Poland. The capital is Minsk.
] |
|
Cetomacrogol
|
D02.033.455.250.700.150 |
|
